This study is testing a new way to help people living with HIV quit smoking. It compares a proactive approach called PrOMOTE with standard care. In PrOMOTE, a pharmacist will call you and offer a personalized plan to help you stop smoking, including medication. You would need to tell them if you don't want the medication sent to your pharmacy. The study is looking for 231 participants who are at least 21 years old, have HIV, currently smoke, and speak English. We want to see if PrOMOTE helps more people quit smoking after 7 days compared to standard care. The study status is unclear.

Study design

This study is an interventional trial that will randomly assign participants to either the PrOMOTE group or standard care. It plans to enroll 231 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary goal is to measure tobacco use abstinence at 7 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.